Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nicotinamide Supplementation and Primary Open-Angle Glaucoma in Patients With Ocular Hypertension.

JAMA ophthalmology·2026
Same author

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026
Same author

Systemic Anemia and the Risk of Diabetic Macular Edema and Anti-VEGF Injections.

Ophthalmology. Retina·2026
Same author

Statin Intensity and the Risk of Noninfectious Uveitis.

Ophthalmology. Retina·2026
Same author

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

American journal of ophthalmology·2026
Same author

Rare Case of Disseminated Histoplasmosis Presenting as Endogenous <i>Histoplasma Capsulatum</i> Endophthalmitis in an Immunocompetent Patient.

Ophthalmic surgery, lasers & imaging retina·2026

Related Experiment Video

Updated: Jul 12, 2026

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Risk and Predictors of Fellow-Eye Involvement Following Unilateral Retinal Artery Occlusion.

Jawad Muayad1, Sam Karimaghaei2, Muhammad Z Chauhan1

  • 1Bernice and Harvey Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Ophthalmology. Retina
|July 9, 2026
PubMed
Summary

Fellow-eye retinal artery occlusion (RAO) affects about 1 in 25 central RAO and 1 in 31 branch RAO patients within 5 years. Risk factors and event patterns suggest different causes, highlighting the need for close monitoring after initial RAO.

Keywords:
BRAOCRAOFellow eyeRetinal artery occlusion

More Related Videos

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
05:20

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion

Published on: November 12, 2020

Related Experiment Videos

Last Updated: Jul 12, 2026

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility
07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion
05:20

A Murine Model of Ischemic Retinal Injury Induced by Transient Bilateral Common Carotid Artery Occlusion

Published on: November 12, 2020

Area of Science:

  • Ophthalmology
  • Neurology
  • Vascular Medicine

Background:

  • Retinal artery occlusion (RAO) is a serious vascular event affecting vision.
  • Understanding the risk of fellow-eye involvement after unilateral RAO is crucial for patient management.
  • Predictors and temporal patterns of fellow-eye RAO require further elucidation.

Purpose of the Study:

  • To determine the 5-year event probability of fellow-eye RAO after unilateral central RAO (CRAO) or branch RAO (BRAO).
  • To analyze the temporal pattern of fellow-eye RAO development.
  • To identify baseline predictors associated with fellow-eye RAO.

Main Methods:

  • Retrospective cohort study of 10,085 CRAO and 9,574 BRAO patients from the TriNetX US Collaborative Network (2015-2025).
  • Kaplan-Meier analysis estimated 5-year event probability.
  • Baseline characteristics were compared between patients with and without fellow-eye RAO using statistical tests with Bonferroni correction.

Main Results:

  • Fellow-eye RAO occurred in 4.06% of CRAO patients and 3.22% of BRAO patients within 5 years.
  • Index RAO type predicted fellow-eye RAO subtype (CRAO to CRAO, BRAO to BRAO).
  • Significant predictors for CRAO included cerebral infarction, carotid stenosis, hypertension, diabetes, diabetic retinopathy, and sleep apnea; for BRAO, predictors included retinal vasculitis, ocular hypertension, and diabetes-related factors.

Conclusions:

  • Fellow-eye RAO incidence is approximately 1 in 25 for CRAO and 1 in 31 for BRAO within 5 years.
  • Concordance of RAO subtype and distinct risk profiles suggest different pathophysiologies.
  • Findings support patient counseling and emphasize close follow-up in the initial months post-RAO.